Table 1—

Demographic and clinical characteristics of the Pro.V.A. study population stratified by metabolic syndrome (weighted data)

OverallMS−MS+P value*
Age (years)74.0 ± 7.073.9 ± 7.074.3 ± 6.9NS
Male sex (%)38.946.426.80.000
BMI (kg/m2)27.8 ± 4.626.4 ± 4.030.1 ± 4.60.000
Waist circumference (cm)97.0 ± 11.493.5 ± 10.6102.7 ± 10.10.000
Systolic blood pressure (mmHg)153 ± 21152 ± 22155 ± 190.000
Diastolic blood pressure (mmHg)84 ± 1184 ± 1183 ± 10NS
Triglycerides (mg/dl)135 ± 74108 ± 50179 ± 860.000
Total cholesterol232 ± 43229 ± 41237 ± 460.000
LDL cholesterol146 ± 37145 ± 36149 ± 390.004
HDL cholesterol59 ± 1663 ± 1552 ± 150.000
Plasma glucose107 ± 3596 ± 19124 ± 460.000
Smoking status (%)
    Never60.755.968.60.000
    Former29.332.424.2
    Current10.011.77.2
Albumin (g/l)4.3 ± 0.44.3 ± 0.44.3 ± 0.4NS
Physical activity ≤4 h/week (%)75.572.680.10.000
Education ≤5 years (%)83.781.787.00.000
Monthly income <500 € (%)59.256.563.60.000
Prevalence rates of metabolic syndrome components (%)
    High blood pressure89.685.496.50.000
    High triglycerides30.810.464.10.000
    Low HDL cholesterol19.14.942.10.000
    Increased waist circumference57.138.288.00.000
    High glucose28.29.958.00.000
Prevalence rates of (%)
    Coronary heart disease7.06.87.2NS
    Cardiovascular diseases23.821.527.60.000
    Other major diseases§57.849.671.20.000
  • Data are means ± SD or %.

  • * P values refer to comparison between those without metabolic syndrome (MS−) and with metabolic syndrome (MS+).

  • Angina and myocardial infarction.

  • Congestive heart failure, stroke, and peripheral artery disease.

  • § Diabetes, chronic pulmonary and kidney diseases, cancer, and/or cognitive impairment.